Home > Doxycycline > Doxycycline(564-25-0)
Doxycycline(564-25-0)
Supplier Product Identification
Physical and Chemical Properties
First Aid Measures
Handling and Storage
Hazards Identification
Exposure Controls/Personal Protection
Fire Fighting Measures
Accidental Release Measures
Stability and Reactivity
Product Identification
Product Name
Doxycycline
Doxycycline
Synonyms
(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
6-Deoxy-5-hydroxytetracycline
6-Deoxytetracycline
alpha-6-Deoxy-5-hydroxytetracycline
alpha-6-Deoxyoxytetracycline
Doxycyclin hyclate
(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
6-Deoxy-5-hydroxytetracycline
6-Deoxytetracycline
alpha-6-Deoxy-5-hydroxytetracycline
alpha-6-Deoxyoxytetracycline
Doxycyclin hyclate
CAS
564-25-0
564-25-0
Formula
C22H24N2O8
C22H24N2O8
Molecular Weight
444.44
444.44
EINECS
209-271-1
209-271-1
RTECS
QI8650000
QI8650000
RTECS Class
Drug; Mutagen; Reproductive Effector; Human Data
Drug; Mutagen; Reproductive Effector; Human Data
Merck
12,3496
12,3496
Beilstein/Gmelin
2230419
2230419
Physical and Chemical Properties
Appearance
Yellow, crystalline powder with slight ethanolic odor.
Yellow, crystalline powder with slight ethanolic odor.
Solubility in water
Slightly soluble
Slightly soluble
Vapor Pressure
2E-24 (25 C)
2E-24 (25 C)
pKa/pKb
4.50 (pKa)
4.50 (pKa)
Partition Coefficient
-.26
-.26
Usage
Medication.
Medication.
First Aid Measures
Ingestion
Flush mouth out with water. Seek medical attention.
Flush mouth out with water. Seek medical attention.
Inhalation
Remove to fresh air.
Remove to fresh air.
Skin
Flush with copious amounts of water for at least 15 minutes.
Flush with copious amounts of water for at least 15 minutes.
Eyes
Flush with copious amounts of water for at least 15 minutes.
Flush with copious amounts of water for at least 15 minutes.
Handling and Storage
Storage
store in a tightly closed container.
store in a tightly closed container.
Handling
All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
Hazards Identification
Inhalation
Allergic reaction. Irritation.
Allergic reaction. Irritation.
Skin
Skin hyperpigmentation has been reported.
Skin hyperpigmentation has been reported.
Eyes
Irritation.
Irritation.
Ingestion
Nausea, vomiting, epigastric burning, and abdominal discomfort have been noted. Tetracycline and doxycycline have been implicated in causing esophageal ulceration, but this is thought to be uncommon.
Nausea, vomiting, epigastric burning, and abdominal discomfort have been noted. Tetracycline and doxycycline have been implicated in causing esophageal ulceration, but this is thought to be uncommon.
Exposure Controls/Personal Protection
Personal Protection
Rubber or vinyl gloves, safety goggles and appropriate laboratory clothings.
Rubber or vinyl gloves, safety goggles and appropriate laboratory clothings.
Respirators
NIOSH approved respirator.
NIOSH approved respirator.
Exposure Effects
Headache, papilledema and benign intracranial hypertension have been reported. Maternal ingestion of tetracyclines during pregnancy may cause tooth discoloration, enamel defects, and other congenital anomalies. <br>Hepatotoxicity, pancreatitis, and renal failure may occur in pregnant women following ingestion of tetracyclines during pregnancy.
Headache, papilledema and benign intracranial hypertension have been reported. Maternal ingestion of tetracyclines during pregnancy may cause tooth discoloration, enamel defects, and other congenital anomalies. <br>Hepatotoxicity, pancreatitis, and renal failure may occur in pregnant women following ingestion of tetracyclines during pregnancy.
Fire Fighting Measures
Fire Fighting
Evacuate area. Wear SCBA and protective clothing. Use agent most suitable for extinguishing surrounding fire.
Evacuate area. Wear SCBA and protective clothing. Use agent most suitable for extinguishing surrounding fire.
Accidental Release Measures
Small spills/leaks
Wear dust respirator and rubber gloves. Sweep up, avoiding dust generation. Place in appropriate container for disposal.
Wear dust respirator and rubber gloves. Sweep up, avoiding dust generation. Place in appropriate container for disposal.
Stability and Reactivity
Stability
Stable at normal temperatures and pressures.
Stable at normal temperatures and pressures.
Decomposition
Toxic fumes.
Toxic fumes.
Contact
More
- Company Name:Molcoo Chemicals Inc.
- Tel: 18672515910
- Fax:
- WebSite:http://www.molcoo.com/
- Company Name:LGM Pharma
- Tel:1-(800)-881-8210
- Fax:615-250-9817
- WebSite:http://www.lgmpharma.com
- Company Name:Nanjing MeiBo Biological Technology Co., Ltd.
- Tel:025-58619198
- Fax:025-58619197
- WebSite:http://www.mbbio.com
- Company Name:XiaoGan ShenYuan ChemPharm co,ltd
- Tel: 15527768850
- Fax:
- WebSite:http://www.farchem.com/
- Company Name:BioBioPha Co., Ltd.
- Tel:0871-65217109 13211707573;
- Fax:0871-65215563
- WebSite:http://www.biobiopha.com